Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gynecological assessment of HG22
RBR-9tf7y5Not yet recruiting
- Sponsor
- Infinant Health
- Start
- Apr 2023
- Countries
- 1
01
Overview
Open-label, single-arm trial in vaginal dryness and vaginitis, sponsored by Infinant Health. Primary endpoint: Gynecological integrity after 21 days of use. Planned start Apr 2023; status: not yet recruiting.
02
Conditions
vaginal drynessvaginitis
Beyond the preview
Go deeper on RBR-9tf7y5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-9tf7y5.